Impact of maternal engrafted cytomegalovirus‐specific CD8+ T cells in a patient with severe combined immunodeficiency
Open Access
- 1 January 2021
- journal article
- case report
- Published by Wiley in Clinical & Translational Immunology
- Vol. 10 (4) , e1272
Abstract
Objectives: In patients with severe combined immunodeficiency (SCID), the immune system often fails to eradicate maternal cells that enter the foetus via the placenta, resulting in transplacental maternal engraftment (TME) syndrome. However, the clinical significance of TME has not been comprehensively elucidated.Methods: Here, we describe a patient with SCID with a novel frameshift IL2RG mutation associated with maternal engrafted CD8+ T cells that had been expanded by viral infection. To evaluate the origin of the expanded T cells, we HLA‐typed the myeloid and T cells of the patient and analysed the immunological characteristics of the expanded CD8+ T cells using T‐cell receptor (TCR) repertoire and flow cytometry analysis.Results: In our patient, the maternal engrafted CD8+ T cells expanded and exerted in vitro antiviral function against human cytomegalovirus (CMV) infection before and after haematopoietic cell transplantation (HCT). After haploidentical HCT from the maternal donor, maternal engrafted CMV‐specific CD8+ T cells were maintained, successfully proliferated and activated against CMV. We found no evidence of acute graft‐versus‐host disease or infectious complications other than recurrent episodes of CMV viraemia, which were well controlled by ganciclovir and, possibly by, the maternal engrafted CMV‐specific CD8+ T cells.Conclusion: Our findings elucidate a possible functional role of TME in controlling CMV infection in patient with SCID and suggest an optimal strategy for donor selection in patients with SCID with TME.Keywords
Funding Information
- National Research Foundation of Korea (2019032869)
This publication has 23 references indexed in Scilit:
- Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency NetworkFrontiers in Immunology, 2019
- Immunological implications of pregnancy-induced microchimerismNature Reviews Immunology, 2017
- Treatment of infants identified as having severe combined immunodeficiency by means of newborn screeningJournal of Allergy and Clinical Immunology, 2017
- Severe combined immunodeficiencies and related disordersNature Reviews Disease Primers, 2015
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experienceJournal of Allergy and Clinical Immunology, 2014
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patientsBlood, 2001
- Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic studyBone Marrow Transplantation, 2001
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968